A detailed history of Cresset Asset Management, LLC transactions in 23and Me Holding Co. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 173,529 shares of ME stock, worth $539,675. This represents 0.0% of its overall portfolio holdings.

Number of Shares
173,529
Previous 179,263 3.2%
Holding current value
$539,675
Previous $69,000 13.04%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.29 - $0.51 $1,662 - $2,924
-5,734 Reduced 3.2%
173,529 $60,000
Q2 2024

Aug 14, 2024

BUY
$0.36 - $0.61 $32,965 - $55,858
91,572 Added 104.43%
179,263 $69,000
Q1 2024

May 15, 2024

BUY
$0.4 - $0.91 $2,293 - $5,217
5,734 Added 7.0%
87,691 $46,000
Q3 2023

Nov 14, 2023

BUY
$0.96 - $2.01 $12,088 - $25,309
12,592 Added 18.15%
81,957 $80,000
Q2 2023

Aug 14, 2023

BUY
$1.59 - $2.29 $110,290 - $158,845
69,365 New
69,365 $121,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $808M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.